Clinical trials
Completed Phase 3 Coronavirus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 43 |
| 2021 | 14 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| BioNTech SE | 6 |
| ModernaTX, Inc. | 5 |
| Novavax | 4 |
| Northwell Health | 2 |
| Novartis Pharmaceuticals | 2 |
| RSV Therapeutics LLC | 2 |
| University of Minnesota | 2 |
| Université de Sherbrooke | 2 |
| AO GENERIUM | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 68 |
| COVID-19 | 61 |
| Severe Acute Respiratory Syndrome | 18 |
| Virus Diseases | 18 |
| Coronaviridae Infections | 13 |
| RNA Virus Infections | 12 |
| Nidovirales Infections | 11 |
| Pneumonia | 5 |
| Respiratory Distress Syndrome | 5 |
| Respiratory Tract Diseases | 4 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.